Natixis Advisors, L.P. Neogenomics Inc Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Neogenomics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 36,976 shares of NEO stock, worth $378,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,976
Previous 33,982
8.81%
Holding current value
$378,264
Previous $501,000
21.56%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$201 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$146 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$66.8 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$63.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$63 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.29B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...